Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron P Vaughn

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Gut Microbes|April 14, 2025
Metagenomic source tracking after microbiota transplant therapySusan L Hoops, Daphne Moutsoglou, Byron P Vaughn, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infectionChristopher Staley, Byron P Vaughn, Carolyn T Graiziger, et al.
Crohn'S & Colitis 360|February 13, 2023
Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel DiseaseDavid E Jonason, Tyson Sievers, Lindsay Trocke, et al.
Inflammatory Bowel Diseases|March 25, 2026
Discordant Clostridioides difficile testing as a predictor of inflammatory bowel disease therapy escalationPavithra Ramakrishnan, James Campbell, Daphne Moutsoglou, et al.
Digestive Diseases and Sciences|October 16, 2020
Microscopic Colitis Is Not an Independent Risk Factor for Low Bone DensityElliot J Graziano, Byron P Vaughn, Qi Wang, et al.
Glomerular Diseases|November 2, 2023
Kidney Biopsy Findings and Clinical Outcomes of US Veterans with Inflammatory Bowel DiseasePrasanth Ravipati, Scott Reule, Alyssa Bren, et al.
ACG Case Reports Journal|January 3, 2022
Adult Intestinal Toxemia Botulism in a Patient With Crohn's DiseaseMohamed A Abdallah, Kevin M Rank, Scott Keeley, et al.
Journal of Clinical Gastroenterology|April 24, 2020
Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel SyndromeJames P Campbell, Claudia Zierold, Ashli M Rode, et al.
Open Forum Infectious Diseases|May 17, 2024
Impact of the Reverse 2-Step Algorithm for <i>Clostridioides difficile</i> Testing in the Microbiology Laboratory on Hospitalized PatientsEvann E Hilt, Byron P Vaughn, Alison L Galdys, et al.
Journal of Crohn'S & Colitis|March 29, 2018
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Ravy K Vajravelu, Byron P Vaughn, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Gut Microbes|April 14, 2025
Metagenomic source tracking after microbiota transplant therapySusan L Hoops, Daphne Moutsoglou, Byron P Vaughn, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infectionChristopher Staley, Byron P Vaughn, Carolyn T Graiziger, et al.
Crohn'S & Colitis 360|February 13, 2023
Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel DiseaseDavid E Jonason, Tyson Sievers, Lindsay Trocke, et al.
Inflammatory Bowel Diseases|March 25, 2026
Discordant Clostridioides difficile testing as a predictor of inflammatory bowel disease therapy escalationPavithra Ramakrishnan, James Campbell, Daphne Moutsoglou, et al.
Digestive Diseases and Sciences|October 16, 2020
Microscopic Colitis Is Not an Independent Risk Factor for Low Bone DensityElliot J Graziano, Byron P Vaughn, Qi Wang, et al.
Glomerular Diseases|November 2, 2023
Kidney Biopsy Findings and Clinical Outcomes of US Veterans with Inflammatory Bowel DiseasePrasanth Ravipati, Scott Reule, Alyssa Bren, et al.
ACG Case Reports Journal|January 3, 2022
Adult Intestinal Toxemia Botulism in a Patient With Crohn's DiseaseMohamed A Abdallah, Kevin M Rank, Scott Keeley, et al.
Journal of Clinical Gastroenterology|April 24, 2020
Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel SyndromeJames P Campbell, Claudia Zierold, Ashli M Rode, et al.
Open Forum Infectious Diseases|May 17, 2024
Impact of the Reverse 2-Step Algorithm for <i>Clostridioides difficile</i> Testing in the Microbiology Laboratory on Hospitalized PatientsEvann E Hilt, Byron P Vaughn, Alison L Galdys, et al.
Journal of Crohn'S & Colitis|March 29, 2018
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Ravy K Vajravelu, Byron P Vaughn, et al.
Pageof 9